Article
Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.
PloS one - 1 Jan 2011
Miyamura Tatsuo, Kanda Tatsuo, Nakamoto Shingo, Wu Shuang, Fujiwara Keiichi, Imazeki Fumio, Yokosuka Osamu
Abstract excerpt
BACKGROUND: We investigated associations between signal transducer and activator of transcription (STAT) 1 in pretreated liver tissues, interleukin (IL) 28B polymorphism and treatment response in hepatitis C virus (HCV)-infected patients treated with peginterferon and ribavirin. METHODS AND FINDINGS: We performed immunostaining analysis of STAT1 in liver tissues and determined IL28B polymorphism at rs8099917. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
